Spironolactone versus placebo for patients experiencing heart failure with preserved ejection fraction: The IMPRESS-AF randomized controlled trial

Research output: Contribution to journalArticle

Details

Original languageEnglish
JournalNIHR Journals Library
Publication statusAccepted/In press - 9 Mar 2020